Physician profile
William M Thompson
NPI 1902872948
$3,352.56
in general payments reported to CMS, 2019-2025
47 companies · $788 in 2025
The $788 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $254 · 2021: $388 · 2022: $512 · 2023: $833 · 2024: $231 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $611.80 | 2023-2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $417.63 | 2020-2025 | Matrixrib |
| Integra Lifesciences Corporation | $285.49 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $190.95 | 2019-2022 | |
| Tela Bio, INC. | $140.37 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acell, INC. | $112.11 | 2019-2020 | |
| Csl Behring | $109.60 | 2020-2023 | Kcentra |
| Ethicon US, LLC | $99.59 | 2019-2024 | Surgicel Nu-Knit, Enseal, Harmonic |
| Solventum Corporation | $82.23 | 2025 | Prevena, Abthera, Activ.A.C. |
| Haemonetics Corporation | $78.01 | 2019-2024 | Teg5000 Hemostasis Analyzer |
| Baxter Healthcare | $76.35 | 2019-2022 | |
| Avita Medical Americas, LLC | $75.90 | 2025 | Cohealyx, Recell, Permeaderm |
| Portola Pharmaceuticals, LLC | $69.35 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $69.29 | 2022-2024 | |
| Heron Therapeutics, INC. | $62.03 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.08 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants |
| Medline Industries LP | $59.41 | 2023 | |
| Kerecis Limited | $55.64 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Z-Medica, LLC | $48.62 | 2019 | |
| Elucent Medical | $46.08 | 2022 | |
| Davol INC. | $41.66 | 2019-2021 | |
| Btg International INC. | $40.96 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $38.69 | 2020-2021 | |
| Avanos Medical | $35.92 | 2020-2021 | |
| La Jolla Pharmaceutical Company | $34.65 | 2023-2024 | Xerava, Giapreza |
| W. L. Gore & Associates, INC. | $28.77 | 2019-2021 | |
| Becton, Dickinson and Company | $27.42 | 2023 | Xenmatrix Ab Surgical Graft |
| Bioventus LLC | $26.73 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.50 | 2024 | Libtayo |
| Trevena, INC. | $23.05 | 2022 | |
| Sanara Medtech INC. | $22.84 | 2025 | Biasurge |
| Axonics, INC. | $22.34 | 2023 | Axonics |
| Innocoll Pharmaceuticals Limited | $20.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.48 | 2023 | Andexxa |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Merck Sharp & Dohme LLC | $17.64 | 2021 | |
| Lifenet Health | $17.48 | 2024 | Theragenesis Wound Matrix |
| Shire North American Group INC | $17.01 | 2019 | |
| Endo Pharmaceuticals INC. | $16.80 | 2024 | Nascobal |
| Alexion Pharmaceuticals, INC. | $15.12 | 2022 | |
| Misonix INC | $14.73 | 2020 | |
| Hologic Sales and Service, LLC | $13.77 | 2023 | Trident Specimen Radiography System |
| Kci USA, INC. | $12.93 | 2022 | |
| Applied Medical Technology INC | $12.83 | 2019 | |
| Pfizer INC. | $12.50 | 2020 | |
| Smith+Nephew, INC. | $12.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.